Anders Sönnerborg Selected Research

Anders Sönnerborg Research Topics

Disease

34	Infections 10/2023 - 03/2002
9	COVID-19 10/2023 - 01/2020
8	HIV Infections (HIV Infection) 01/2020 - 05/2002
6	Viremia 01/2023 - 07/2009
5	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 03/2002
3	Necrosis 07/2010 - 04/2006
2	Disease Progression 10/2023 - 01/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2022
2	Neoplasms (Cancer) 03/2022 - 01/2017
2	Lymphoma (Lymphomas) 01/2022 - 01/2013
2	Severe Acute Respiratory Syndrome 04/2021 - 01/2021
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2021 - 01/2013
2	Persistent Infection 10/2014 - 04/2011
1	Hypotension (Low Blood Pressure) 11/2022
1	Sepsis (Septicemia) 11/2022
1	Herpes Genitalis (Genital Herpes) 11/2022
1	Inflammation (Inflammations) 02/2021
1	Hepatitis 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Chronic Disease (Chronic Diseases) 01/2020
1	HIV Seropositivity 01/2018
1	Adenocarcinoma in Situ 01/2018
1	Uterine Cervical Dysplasia 01/2018
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018
1	Rupture 01/2018
1	Virus Diseases (Viral Diseases) 01/2017
1	Opportunistic Infections (Opportunistic Infection) 01/2014
1	Superinfection 11/2013
1	Anus Neoplasms (Anal Cancer) 01/2013
1	Thrombocytopenia (Thrombopenia) 01/2013
1	Herpes Zoster 01/2013
1	Seborrheic Dermatitis 01/2013
1	Exanthema (Rash) 01/2013
1	Hepatitis B 01/2013
1	Leukopenia 01/2013
1	Hyperbilirubinemia 04/2010

Drug/Important Bio-Agent (IBA)

8	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2006
7	Antiviral Agents (Antivirals)IBA 05/2023 - 01/2007
6	HMGB1 Protein (HMG1)IBA 01/2012 - 04/2006
5	CytokinesIBA 11/2022 - 03/2002
5	Proteins (Proteins, Gene)FDA Link 01/2011 - 04/2006
4	Reverse Transcriptase InhibitorsIBA 01/2018 - 04/2011
3	VaccinesIBA 10/2023 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2014
3	IntegrasesIBA 03/2022 - 04/2011
3	LigandsIBA 01/2019 - 01/2012
3	NucleosidesIBA 07/2014 - 01/2008
3	Atazanavir Sulfate (Reyataz)FDA Link 03/2013 - 04/2007
2	DipeptidesIBA 05/2023 - 01/2021
2	AntibodiesIBA 01/2021 - 03/2004
2	ChemokinesIBA 01/2018 - 03/2007
2	AntigensIBA 02/2016 - 03/2004
2	FlagellinIBA 12/2015 - 01/2012
2	Interleukin-7 (Interleukin 7)IBA 08/2015 - 07/2009
2	Ritonavir (Norvir)FDA Link 03/2013 - 04/2007
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2011 - 04/2011
2	PerforinIBA 03/2007 - 05/2002
2	Granzymes (Granzyme)IBA 03/2007 - 05/2002
1	tocilizumab (atlizumab)FDA Link 01/2023
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2023
1	abacavir (Ziagen)FDA Link 01/2023
1	Glycoproteins (Glycoprotein)IBA 11/2022
1	GelsIBA 11/2022
1	Integrase InhibitorsIBA 03/2022
1	Chemokine ReceptorsIBA 01/2022
1	malic acid (malate)IBA 01/2022
1	Butyrates (Butyrate)IBA 01/2022
1	Succinic Acid (Succinate)IBA 01/2022
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 01/2022
1	LipidsIBA 02/2021
1	AntioxidantsIBA 02/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	gag Gene Products (gag Protein)IBA 01/2021
1	Mannose (D-Mannose)IBA 01/2021
1	CarbonIBA 01/2021
1	Viral DNAIBA 01/2020
1	ChromatinIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Drug CombinationsIBA 01/2018
1	KynurenineIBA 01/2017
1	Tryptophan (L-Tryptophan)FDA Link 01/2017
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 01/2017
1	Protease Inhibitors (Protease Inhibitor)IBA 04/2016
1	HIV AntibodiesIBA 02/2016
1	HLA-DR Antigens (HLA-DR)IBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 07/2014
1	Indicators and Reagents (Reagents)IBA 01/2013
1	Intravenous Immunoglobulins (IVIG)FDA Link 06/2011
1	DNA (Deoxyribonucleic Acid)IBA 04/2011
1	Peptide Hydrolases (Proteases)FDA Link 04/2011
1	LipopolysaccharidesIBA 07/2010
1	EnzymesIBA 07/2010
1	ImmunosorbentsIBA 07/2010

Therapy/Procedure

17	Therapeutics 01/2023 - 01/2003
7	Art Therapy 01/2023 - 01/2006
2	Aftercare (After-Treatment) 01/2018 - 04/2011
1	Condoms (Condom) 01/2021
1	Highly Active Antiretroviral Therapy (HAART) 01/2021
1	Contraindications 01/2018